On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled incredible new data from whole genome sequencing of its half a million participants.

This is set to drive the discovery of new diagnostics, treatments and cures. Uniquely, it is also available to approved researchers worldwide, via a protected database containing only de-identified data (for example, name, address, date of birth, name of GP and more stripped out).